Home - Sitemap
  • About us
    • About Algeta
    • Corporate Strategy
    • Management
    • Board of Directors
    • Code of Ethics
  • Products
    • Pipeline
    • Alpharadin
    • TH-1
  • Clinical trials
    • ALSYMPCA
    • BC1-09 Breast
    • BC1-10 Combo
  • R & D
    • Technology Overview
    • Alpha-Pharmaceuticals
  • News & Media
    • Press releases
    • Events
    • Publications PDF
    • Pictures & logo
    • Media contact
    • Subscription
  • Investors
    • Share Price Information
    • Reports & Presentations
    • Webcast
    • Main Shareholders
    • Oslo Stock Exchange
    • OSE Announcements
    • Analyst Coverage
    • Financial Calendar
    • Corporate Governance
    • Board of Directors
    • Management
    • Subscription
    • IR contacts
  • Partners
    • Overview
  • Contact
    • Contact details
    • Directions
    • Careers

Main Shareholders

    • Share Price Information »
    • Reports & Presentations »
    • Main Shareholders »
      • Orgin country

    • Oslo Stock Exchange »
    • OSE Announcements »
    • Analyst Coverage »
    • Financial Calendar »
    • Corporate Governance »
    • Board of Directors »
    • Management »
    • Subscription »
    • IR contacts »

Algeta ASA - PO Box 54 Kjelsås - NO-0411 Oslo - Norway - Phone: +47 23 00 79 90 - Telefax: +47 23 00 79 91

How to find us | Disclaimer